At a Glance
| Mucuna Pruriens | Fadogia Agrestis | |
|---|---|---|
| Class | Supplement | Supplement |
| Common Dose (oral) | 100–300 mg (L-DOPA equivalent) | 300–600 mg |
| Total Duration | 1.8–4.5 hrs | 5–11 hrs |
| Routes | Oral | Oral |
Mucuna Pruriens, a Supplement, and Fadogia Agrestis, a Supplement, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Supplements, meaning they share a common pharmacological foundation. They share 6 documented effects in common, with 9 effects unique to Mucuna Pruriens and 1 unique to Fadogia Agrestis. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Mucuna Pruriens | Fadogia Agrestis | |
|---|---|---|
| Class | Supplement | Supplement |
| Common Dose (oral) | 100–300 mg (L-DOPA equivalent) | 300–600 mg |
| Total Duration | 1.8–4.5 hrs | 5–11 hrs |
| Routes | Oral | Oral |
| Effects | 15 documented | 7 documented |
| Level | Mucuna Pruriens | Fadogia Agrestis |
|---|---|---|
| Threshold | 25 mg (L-DOPA equivalent) | 100 mg |
| Light | 50–100 mg (L-DOPA equivalent) | 200–300 mg |
| Common | 100–300 mg (L-DOPA equivalent) | 300–600 mg |
| Strong | 300–500 mg (L-DOPA equivalent) | 600–1000 mg |
| Heavy | 600 mg (L-DOPA equivalent) | 1000 mg |
Mucuna Pruriens
Fadogia Agrestis
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.